Pillstats
Rx only · Capsule, Extended Release · Oral

Cyclobenzaprine Hydrochloride

Brands: Amrix · Cyclobenzaprine Hydrochloride

14 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US30 NDCs
14 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)21949
US makers14 labelers
Packages67
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$5.20$10.41$15.61$20.81Feb 2025Mar 2026Jul 2026
$17.402
Latest avg · Jul 22, 2026
+530%
Since Feb 19, 2025
14
Active US suppliers
39%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3366731.0K1.3K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.2K
Rx · 2026 Q1
37K
Units dispensed
+29%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it14 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Proficient Rx LPunknown18SUPPLYING
Bryant Ranch Prepackrepackager8SUPPLYING
Asclemed USA, Inc.unknown8SUPPLYING
PHOENIX RX LLCunknown6SUPPLYING
Advanced Rx of Tennessee, LLCunknown6SUPPLYING
REMEDYREPACK INC.repackager4SUPPLYING
Macleods Pharmaceuticals Limitedunknown4SUPPLYING
Preferred Pharmaceuticals Inc.unknown3SUPPLYING
Cephalon, LLCunknown2SUPPLYING
Upsher-Smith Laboratories, LLCunknown2SUPPLYING
Amneal Pharmaceuticals of New York LLCunknown2SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown2SUPPLYING
Doc Rxunknown1SUPPLYING
Direct_Rxunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.